Yotaro Ochi
-
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 4
-
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- Lymphoma Diagnosis and Treatment 4
-
- T-cell and Retrovirus Studies 2
-
- Protein Degradation and Inhibitors 4
- RNA Research and Splicing 4
Yotaro Ochi
21 papers receiving 161 citations
Peers
Comparison fields: 5 of 37
- Hematology 33
- Genetics 28
- Pathology and Forensic Medicine 46
- Immunology 46
- Oncology 46
Countries citing papers authored by Yotaro Ochi
This map shows the geographic impact of Yotaro Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yotaro Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yotaro Ochi more than expected).
Fields of papers citing papers by Yotaro Ochi
This network shows the impact of papers produced by Yotaro Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yotaro Ochi. The network helps show where Yotaro Ochi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yotaro Ochi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 38 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 2 | |
| 15 | 2019 | 7 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 33 | |
| 19 | 2015 | 20 | |
| 20 | 2015 | 1 |
About Yotaro Ochi
Yotaro Ochi is a scholar working on Microbiology, Hematology and Genetics, having authored 23 papers that have together received 161 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (5 papers), Protein Degradation and Inhibitors (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), RNA Research and Splicing (4 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Hematology (33 citations), Genetics (28 citations) and Pathology and Forensic Medicine (46 citations). Yotaro Ochi has collaborated with scholars based in Japan, Sweden and United Kingdom. Frequent co-authors include Seishi Ogawa, Takayuki Ishikawa, Yukihiro Imai, Nobuhiro Hiramoto, Noboru Yonetani, Hisako Hashimoto, Akiko Matsushita, Satoshi Yoshioka, Yuichiro Ono and Yasuhiro Kazuma. Their work appears in journals such as Blood, International Journal of Hematology, Genes & Development, British Journal of Haematology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.